Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) was $1.50 for the day, down -3.23% from the previous closing price of $1.55. In other words, the price has decreased by -$3.23 from its previous closing price. On the day, 2.8 million shares were traded.
Ratios:
Our analysis of IRWD’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.71 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1.94. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 4.66.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on September 09, 2024, initiated with a Market Perform rating and assigned the stock a target price of $5.
On August 08, 2024, CapitalOne Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $12 to $4.
On January 17, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $21.Craig Hallum initiated its Buy rating on January 17, 2024, with a $21 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 10 ’25 when MCCOURT Thomas A sold 139,064 shares for $1.76 per share. The transaction valued at 244,753 led to the insider holds 1,160,634 shares of the business.
Silver Ronald sold 12,048 shares of IRWD for $21,204 on Feb 10 ’25. The Principal Accounting Officer now owns 279,655 shares after completing the transaction at $1.76 per share. On Feb 10 ’25, another insider, Shetzline Michael, who serves as the SVP, CMO, Head-Res&Drug of the company, sold 41,269 shares for $1.76 each. As a result, the insider received 72,633 and left with 554,007 shares of the company.
Valuation Measures:
As of this moment, Ironwood’s Price-to-Earnings (P/E) ratio for their current fiscal year is 138.89, and their Forward P/E ratio for the next fiscal year is 6.92. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.68.
Stock Price History:
Over the past 52 weeks, IRWD has reached a high of $9.31, while it has fallen to a 52-week low of $1.43. The 50-Day Moving Average of the stock is -48.73%, while the 200-Day Moving Average is calculated to be -66.55%.
Shares Statistics:
A total of 160.03M shares are outstanding, with a floating share count of 155.19M. Insiders hold about 3.02% of the company’s shares, while institutions hold 103.00% stake in the company.
